1. Home
  2. CRSP vs OGS Comparison

CRSP vs OGS Comparison

Compare CRSP & OGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRSP
  • OGS
  • Stock Information
  • Founded
  • CRSP 2013
  • OGS 1906
  • Country
  • CRSP Switzerland
  • OGS United States
  • Employees
  • CRSP N/A
  • OGS N/A
  • Industry
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • OGS Oil/Gas Transmission
  • Sector
  • CRSP Health Care
  • OGS Utilities
  • Exchange
  • CRSP Nasdaq
  • OGS Nasdaq
  • Market Cap
  • CRSP 4.9B
  • OGS 4.3B
  • IPO Year
  • CRSP 2016
  • OGS N/A
  • Fundamental
  • Price
  • CRSP $57.68
  • OGS $72.97
  • Analyst Decision
  • CRSP Buy
  • OGS Buy
  • Analyst Count
  • CRSP 16
  • OGS 6
  • Target Price
  • CRSP $70.73
  • OGS $77.75
  • AVG Volume (30 Days)
  • CRSP 3.7M
  • OGS 398.4K
  • Earning Date
  • CRSP 08-04-2025
  • OGS 08-05-2025
  • Dividend Yield
  • CRSP N/A
  • OGS 3.68%
  • EPS Growth
  • CRSP N/A
  • OGS 3.26
  • EPS
  • CRSP N/A
  • OGS 4.20
  • Revenue
  • CRSP $37,675,000.00
  • OGS $2,260,428,000.00
  • Revenue This Year
  • CRSP $28.31
  • OGS $23.68
  • Revenue Next Year
  • CRSP $268.05
  • OGS $4.00
  • P/E Ratio
  • CRSP N/A
  • OGS $17.34
  • Revenue Growth
  • CRSP N/A
  • OGS 7.73
  • 52 Week Low
  • CRSP $30.04
  • OGS $65.75
  • 52 Week High
  • CRSP $71.13
  • OGS $82.25
  • Technical
  • Relative Strength Index (RSI)
  • CRSP 52.32
  • OGS 48.44
  • Support Level
  • CRSP $61.13
  • OGS $72.00
  • Resistance Level
  • CRSP $69.58
  • OGS $75.76
  • Average True Range (ATR)
  • CRSP 3.89
  • OGS 1.15
  • MACD
  • CRSP -0.71
  • OGS -0.04
  • Stochastic Oscillator
  • CRSP 28.46
  • OGS 25.80

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About OGS ONE Gas Inc.

ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. The company controls considerable market shares in Oklahoma and Kansas.

Share on Social Networks: